Statins increase the risk of cardiovascular disease in women

This paper was published in the Open Journal of Endocrine and Metabolic Diseases, Vol. 3 No. 3, 2013, pp. 179-185

 

Study title and authors:

The Ugly Side of Statins. Systemic Appraisal of the Contemporary Un-Known Unknowns

S. Sultan and N. Hynes

 

This paper can be accessed at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=34065

This paper undertook a comprehensive review of the scientific literature for articles relating to cardiovascular primary prevention and statin side effects.

 

The review found:

(a) There is a categorical lack of clinical evidence to support the use of statin therapy in primary prevention.

(b) Not only is there a dearth of evidence for primary cardiovascular protection, there is ample evidence to show that statins actually augment cardiovascular risk in women, patients with Diabetes Mellitus and in the young.

(c) Statins are associated with triple the risk of coronary artery and aortic artery calcification.
(d) A review of the use of statins found evidence of selective reporting of outcomes and failure to report adverse events.